You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › March › 10
FDA
4 months ago
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
page 1 of 1